Loading clinical trials...
Loading clinical trials...
Extended Compassionate Use Program (UCA) With Inhalational Ibuprofen in Patients With Acute Respiratory Pathology, Mediated by COVID-19.
Conditions
Interventions
Inhaled Hypertonic ibuprofen
Locations
1
Argentina
Centro de Excelencia en Productos y Procesos Córdoba
Córdoba, Argentina
Start Date
May 1, 2020
Primary Completion Date
January 1, 2021
Completion Date
January 1, 2021
Last Updated
June 11, 2020
NCT06716502
NCT06631287
NCT07168408
NCT04885504
NCT06495021
NCT05780099
Lead Sponsor
Química Luar SRL
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions